INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
98 hedge funds and large institutions have $570M invested in Infinity Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
2.83%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
16
Increased
37
Reduced
29
Closed
21
Calls
$4.43M
Puts
$9.12M
Net Calls
-$4.69M
Net Calls Change
-$4.48M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$15M |
| 2 |
HM
HealthCor Management
New York
|
+$12.5M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.32M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$7.42M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.79M |
Top Sellers
| 1 |
QF
QVT Financial
New York
|
-$9.96M |
| 2 |
VAM
Visium Asset Management
New York
|
-$5.97M |
| 3 |
PA
Perceptive Advisors
New York
|
-$4.83M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.59M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.38M |
